logo
Share SHARE
FONT-SIZE Plus   Neg

Onyx Pharma Loss Widens In Q1

Onyx Pharmaceuticals, Inc. (ONXX) Wednesday reported a first-quarter loss of $56.2 million or $0.88 per share, which widened from $49.2 million or $0.78 per share in the same period last year.

Adjusted loss for the period was $43.5 million or $0.68 per share, compared to $14.2 million or $0.23 per share last year.

On average, 12 analysts polled by Thomson Reuters expected a loss of $0.63 per share for the first quarter. Analysts' estimates typically exclude special items.

First-quarter revenues increased 7 percent to $72.0 million from $67.1 million last year. Analysts expected revenues of $70.04 million for the period.

Operating expenses for the period totaled $122.8 million, up from $108.5 million last year.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
10 Worst Places To Raise A Family Whether you are a young couple building a nest or seasoned parents looking for a change of scenery, there are number of places around the country that should be avoided, according to personal finance website WalletHub. They looked at mainly five categories for... A passenger has filed a lawsuit against Canadian budget airline Sunwing Airlines for serving him cheap sparkling wine instead of champagne on board a flight, according to media reports. The Canadian passenger, Daniel MacDuff, reportedly boarded his Sunwing flight to Cuba in February, on a flight package that advertised a complimentary on-board champagne toast. Senate Health Committee Chairman Lamar Alexander, R-Tenn., and ranking member Patty Murray, D-Wash., announced Thursday that twenty-two other Senators are cosponsoring their bipartisan plan to provide short-term stability to Obamacare. The bipartisan bill includes a two-year extension of the cost-sharing...
comments powered by Disqus
Follow RTT